Castelion's $1B round is priced like a factory, not a startup

Castelion, a Torrance, California missile maker founded in 2022 by three former SpaceX executives, said it closed a $1 billion Series C at a $13 billion valuation, with JPMorganChase's Strategic Investment Group, Andreessen Horowitz and funds managed by Carlyle co-leading the $800 million equity portion ^[1][2][3]. The order book behind it is why this reads as an industrial event rather than a funding headline: more than $500 million in US military contracts booked over 18 months, and a framework agreement with the Department of War targeting a minimum of 500 Blackbeard missiles a year once testing wraps ^[4][5].

Start with the structure of the money, because it is unusual. The $1 billion is $800 million of equity plus a $250 million revolving credit facility ^[1], which sums to $1.05 billion and means the headline number includes credit capacity rather than cash on the balance sheet ^[6]. The co-leads are a bank's strategic investment arm, private equity funds and a venture firm ^[2], with new investor T. Rowe Price Associates joining alongside returning backers Lightspeed, Lavrock, Altimeter, General Catalyst and Interlagos ^[7]. T. Rowe's Emma Norchet pointed to contracts in hand, a manufacturing campus built with the company's own capital, and unit economics that improve with scale as unusual for a private company ^[8]. That is a public-markets underwriting note, not a seed memo.

Now the price. At $13 billion against more than $500 million of booked contracts, the valuation is roughly 26 times the contract base ^[9], and about 10 times the roughly $1.27 billion Castelion has raised in total, excluding the new revolver ^[10][11]. The escalation has been fast: a $5.4 million pre-seed led by Lavrock in April 2023, a $14.2 million seed later that year, a $70 million Series A led by Lightspeed in January 2025 with $30 million of venture debt from Silicon Valley Bank, and a $350 million Series B co-led by Altimeter and Lightspeed in December 2025 ^[12]. The new equity is about 2.3 times the Series B ^[13].

The thesis is manufacturing, not physics. Chief executive Bryon Hargis, who founded the company with Sean Pitt and Andrew Kreitz, has argued that commercial manufacturing discipline could out-produce primes such as Lockheed Martin and RTX rather than out-engineer them ^[14], and he described the round as turbocharging American production of Blackbeard ^[15]. Lightspeed's Ravi Mhatre said the company is now mixing its own propellant in New Mexico and shipping hardware to the services ^[16]. Castelion has taken Blackbeard from a blank sheet to a Pentagon program of record in under four years, with fielding targeted for 2027 ^[4][17]. The backdrop is Washington's concern that it has fallen behind China on hypersonics, weapons that fly above Mach 5 and maneuver enough to evade existing air defences ^[18].

What to watch: whether the 2027 fielding date holds ^[17], since the 500-a-year rate is explicitly conditional on testing finishing ^[5]; the per-missile price that a 500-unit annual line implies, which determines whether the taxpayer-affordability claim survives contact with a program office ^[15]; and whether the revolver gets drawn, which would tell you the working capital cost of ramping a physical line ^[1]. Also watch the next comparable raise. If bank balance sheets and buyout funds keep co-leading these rounds ^[2], the venture framing of defense tech is already out of date.